Direxion Daily S&P Biotech Bear 3X ETF
LABD
6 hedge funds and large institutions have $1.99M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
96% more call options, than puts
Call options by funds: $4.24M | Put options by funds: $2.17M
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
66% less capital invested
Capital invested by funds: $5.78M → $1.99M (-$3.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$841K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$229K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$76.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$76.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.38M |
| 2 |
VF
Virtu Financial
New York
|
-$917K |
| 3 |
CT
CMT Trading
Chicago,
Illinois
|
-$286K |
| 4 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$286K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$86K |
LABD Hedge Fund Activity: Q4 2015 in Review
6 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2015, worth a combined $1.99M — down 66% from $5.78M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LABD and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $841K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.38M sold.
- 6 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2015, down from 8 in Q3 2015.
- Funds reported $1.99M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2015, down 66% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2015 and 4 closed out, a net change of -2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2015 was Jane Street, an estimated $841K added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2015 was Susquehanna International Group, an estimated $1.38M sold.
Based on aggregated 13F filings for Q4 2015.